Atlas Trials

Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Males

Clinical trial NCT06841926 · COMPLETED

Trial details

NCT number
NCT06841926
Sponsor
Nanjing Zenshine Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Respiratory Viral Infection
Start date
2025-02-20
Primary completion
2025-04-18
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.